This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Lyrica

Starting date:
January 9, 2013
Posting date:
January 21, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Dosage, Labelling and Packaging, Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-16875

Recalled Products

  1. Lyrica

Reason

This recall is a result of an investigation into the possibility that bottles may contain LYRICA 150 mg Capsules.

Depth of distribution

Wholesalers and pharmacies in Canada.

Affected products

A. Lyrica

DIN, NPN, DIN-HIM
DIN 0226841
Dosage form

Capsule

Strength

25 mg

Lot or serial number

0659071

Companies
Recalling Firm
Pfizer Canada Inc.
17300 Trans-Canada Highway
Kirkland
H9J 2M5
Quebec
CANADA
Marketing Authorization Holder
Pfizer Canada Inc.
17300 Trans-Canada Highway
Kirkland
H9J 2M5
Quebec
CANADA

Date modified: